Loading clinical trials...

Validation Study of an Advanced Blood Pressure Monitor | Clinical Trials | Clareo Health

COMPLETEDNA

Validation Study of an Advanced Blood Pressure Monitor

Study of Validation of the Advanced Blood Pressure Monitor Withings WPM04 for the Detection of Anomalies of Arterial Pressure, Arrhythmia and Valvular Heart Diseases

NCT04030494•Withings

View on ClinicalTrials.gov

Summary

The proposed clinical study aims to validate the effectiveness of the WPM04 blood pressure monitor developed by Withings as a diagnostic tool for cardiovascular disorders. The detection of cardiovascular disorders is oriented along three axes, namely the measurement of blood pressure, the identification of rhythm disorders such as atrial fibrillation and the identification of heart murmur indicating valvular heart disease.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female over 18 years old,
•Subject who signed the consent form,
•Subject affiliated to a social security scheme or entitled.

Exclusion Criteria

•Underage subject;
•Subject who refused to participate in the study;
•Subject participating in other research or clinical studies;
•Subject with body mass index greater than 35 kg/m2;
•Subject in linguistic or psychic incapacity to sign an informed consent;
•Subject with congenital cardiomyopathy;
•Subject with aorto-venous fistula;
•Subject with pulmonary pathology that may degrade the quality of the recording;
•Subject presenting a serious pathology compromising the realization of the examinations envisaged in the test;
•Subject with an arm injury incompatible with the use of an armband sphygmomanometer;
+5 more criteria

Locations (1)

Clinique AXIUM Centre de cardiologie

Aix-en-Provence, France

Key Dates

Start Date

March 13, 2019

Primary Completion Date

June 13, 2019

Completion Date

June 13, 2019

Last Updated

August 5, 2019

Enrollment

218

ACTUAL participants

Conditions

Atrial FibrillationHypertensionValvular Heart Disease

Interventions

BP measurement

DIAGNOSTIC_TEST

AF detection

DIAGNOSTIC_TEST

VHD detection

DIAGNOSTIC_TEST

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITINGPHASE2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820

Pulmonary Hypertension

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 5, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Validation Study of an Advanced Blood Pressure Monitor

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

The CONFORM Pivotal Trial

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study